| Specific Topics of Lobbying Communications |
Intended Outcomes |
Associated Subject Matters |
Discussions with BC government officials/organizations and elected representative to obtains public reimbursement of AstraZeneca Canada (AZC) innovative treatments for BC Citizens that require access to these treatments, including health system resilience policy and environmental considerations in health care. These discussions will take place with BC government bodies as Pharmacare, the BC Cancer Agency and First Nations Health Authority. This will include discussions on how best to conclude Product Listing Agreement and health care delivery discussions with each of these public entities.
|
-
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
-
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Discussions with BC Government officials including the Ministry of Finance , organizations and elected representatives to discuss funding for AZ's innovation pharmaceuticals and biopharmaceuticals. To encourage the BC government and various ministries to recognize the importance of investments mad in R&D within the province and how these investments lead to the health development of BC's health ecosystem.
|
-
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
-
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Finances and Budgets
|
|